Human Gene Therapy

About This Journal:

  • Print This Page
  • Subscribe to an RSS Feed

Sample Content

LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Human Gene Therapy

Editor-in-Chief: Terence R. Flotte, MD
Deputy Editors, Europe: Nathalie Cartier, MD and Thierry VandenDriessche, PhD
Deputy Editors, U.S.: Barry J. Byrne, MD, PhD and Mark A. Kay, MD, PhD
Human Gene Therapy Editor: Guangping Gao, PhD
Methods Editor: Hildegard Büning, PhD
Clinical Development Editor: James M. Wilson, MD, PhD

ISSN: 1043-0342 • Online ISSN: 1557-7422 • Published 22 issues annually

Current Volume: 29

Latest Impact Factor* is 4.187

*2016 Journal Citation Reports® (Clarivate Analytics, 2017)

Aims & Scope

Human Gene Therapy Methods Latest Impact Factor* 1.831 
Human Gene Therapy Clinical Development Latest Impact Factor* 2.490 

Featured Press Releases and Editorial Content

  • Chinese Research Advances Highlighted in Special Issue of Human Gene Therapy...Read More
  • New Study Shows Severe Toxicity with High-Dose AAV9-Based Gene Therapy in Animal Models...Read More
  • Gene Delivery of Drugs Directly into Arthritic Joints Is Making the Leap to Patients...Read More
  • Inflammatory Factors Linked to Inhibition of Factor VIII Gene Therapy in Hemophilia A...Read More
  • German Research Advances in Cancer and Blood Disorders Reported in Human Gene Therapy...Read More
  • Researchers Use Mini Form of Replacement Gene to Delay Photoreceptor Degeneration in Leber Congenital Amaurosis...Read More
  • New Gene Delivery Approach Could Allow Long-Term Persistence in Proliferating Cells...Read More
  • Will AAV Vectors Have a Role in Future Novel Gene Therapy Approaches?...Read More

Aims & Scope

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.

The Journal is divided into three parts. Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products.

Complete HGT Program coverage includes:

  • Improvements in vector developments
  • Delivery systems
  • Cell therapy
  • Small nucleic acid therapeutics, including RNAi
  • Clinical trials and animal models
  • Clinical protocols
  • Pre-clinical animal and in vitro studies to assess the safety of gene and cell therapy products used to support clinical applications
  • Clinical trials including those in which the results are confirmatory or negative
  • Topical issues related to the commercial development of gene and cell therapy products

Human Gene Therapy was voted one of the most influential journals in Biology and Medicine over the last 100 years by the Biomedical & Life Sciences Division of the Special Libraries Association.

Human Gene Therapy, HGT Methods, and HGT Clinical Development are under the editorial leadership of Editor-in-Chief Terence R. Flotte, MD, University of Massachusetts Medical School; Deput Editors Europe Nathalie Cartier, MD, INSERM, and Thierry VandenDriessche, PhD, Free University of Brussels (VUB); Deputy Editors U.S. Barry J. Byrne, MD, PhD, Powell Gene Therapy Center, University of Florida, College of Medicine and Mark A. Kay, MD, PhD, Stanford University School of Medicine; Human Gene Therapy Editor Guangping Gao, PhD, University of Massachusetts Medical School; Methods Editor Hildegard Büning, PhD, University of Cologne; Clinical Development Editor James M. Wilson, MD, PhD, University of Pennsylvania School of Medicine, Gene Therapy Program; and other leading investigators. View the entire editorial board.

Audience: Geneticists, medical geneticists, molecular biologists, virologists, experimental researchers, and experimental medicine specialists, among others.

Human Gene Therapy and HGT Methods provide “Instant Online” publication 72 hours after acceptance

This subscription includes:


Read Online

Editor-in-Chief: Terence R. Flotte, MD
ISSN: 1043-0342 • Monthly • Online ISSN: 1557-7422
Editorial Board   •   Author Information   •   Subscribe

Human Gene Therapy is the definitive peer-reviewed rapid-publication journal covering all aspects of human gene therapy.  The Journal publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including humans with in-depth coverage of DNA, RNA, and cell therapies. Improvements in vector development, delivery systems, and animal models, particularly in the areas of cancer, heart disease, viral disease, genetic disease, and neurological disease, are covered. 



Read Online

Editor-in-Chief: Terence R. Flotte, MD
ISSN: 1946-6536  • Bimonthly  •  Online ISSN: 1946-6544
Editorial Board  •   Author Information  •  Subscribe

Human Gene Therapy Methods (HGT Methods) publishes technological advances in cell and gene therapy that promote the development of gene therapy products into successful therapeutics. The Journal breaks new ground as the first to exclusively focus on the applications of gene therapy to product testing and development.



Read Online

Editor-in-Chief: Terence R. Flotte, MD
ISSN: 1043-0342  • Quarterly  •  Online ISSN: 1557-7422
Editorial Board  •   Author Information  •  Subscribe

Human Gene Therapy Clinical Development publishes data relevant to the regulatory review and commercial development of cell and gene therapy products. Pre-clinical papers focus on pharmacology/toxicity/bio-distribution experiments used in the review of proposed clinical trials and will contain sufficient information to allow referencing between products within the same technology platform when appropriate.


[ Back to Top ]

The Official Journal of nine international societies:

DG-GT e.V.

 

Indexed/Abstracted in:

MEDLINE; PubMed; PubMed Central; Current Contents®/Life Sciences; Science Citation Index Expanded; Science Citation Index®; Biotechnology Citation Index®; Biological Abstracts; BIOSIS Previews; Journal Citation Reports/Science Edition; Derwent Drug File; EMBASE/Excerpta Medica; EMBiology; Scopus; Chemical Abstracts; ProQuest databases
 

Come See Us!

Show more events...

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Nucleic Acid Therapeutics

    Nucleic Acid Therapeutics

    formerly Oligonucleotides

    Focuses on cutting-edge research and applications to find and examine new approaches using nucleic acids in therapeutics including oligonucleotides, gene modification, aptamers, RNA nanoparticles, ribozymes, and more.

    The CRISPR Journal

    The CRISPR Journal

    The CRISPR Journal delivers groundbreaking multidisciplinary research, advances, and commentary on CRISPR, the extraordinary technology that gives scientists the power to cure disease and sculpt evolution.

    Stem Cells and Development

    Stem Cells and Development

    Globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings on stem cells of all tissue types and their potential therapeutic applications.

    Genetic Testing and Molecular Biomarkers

    Genetic Testing and Molecular Biomarkers

    Covers all areas of molecular, biochemical, and clinical genetic testing; ethical, legal, social, and economic aspects of genetic testing; issues concerning effective genetic counseling; and molecular biomarkers.

    Zebrafish

    Zebrafish

    Solely focused on disseminating the latest cutting-edge advances in the zebrafish as a model organism for the study of vertebrate development, with attention to other aquarium species including medaka, Fugu, and Xiphophorus.

    Gender and the Genome

    Gender and the Genome

    Through evidence-based original research, reviews, perspectives, and commentaries, Gender and the Genome illuminates the impact of biological sex on technology and its effects on human life.

Browse All Publications »